Restoring Vascular and Insulin Function To Augment Anti-Amyloid Therapy in Alzheimer's Disease

NCT07756294 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: Empagliflozin
DRUG: Insulin
DRUG: Insulin Placebo
DRUG: Empagliflozin Placebo

Sponsor

Wake Forest University Health Sciences